Significant dissociation of brain and plasma kinetics with antipsychotics

Molecular Psychiatry
J TauscherS Kapur

Abstract

Current dosing regimens of psychotropic drugs are based on plasma kinetic considerations, although it is unclear whether plasma levels faithfully reflect brain kinetics of drugs.(1,2) To examine this, we compared the kinetics of plasma levels of two widely used antipsychotics, olanzapine and risperidone, vs the time course of their effects in the brain. We used positron emission tomography (PET) and [(11)C]-labeled ligands to quantify striatal and extra-striatal dopamine-2 (D(2)), and cortical serotonin-2A (5-HT(2A)) receptor occupancy in healthy subjects after a single dose, and in patients chronically treated for psychosis. We found a significant dissociation of brain and plasma kinetics. Mean plasma elimination half-lives of single doses of olanzapine and risperidone were 24.2 and 10.3 h, respectively, whereas it took on average 75.2 h with olanzapine, and 66.6 h with risperidone to decline to 50% of their peak striatal D(2) receptor occupancy. We found similar discrepancies between the time course of plasma levels and extra-striatal D(2) as well as 5-HT(2A) receptor occupancy. Our results question the current reliance on plasma kinetics as the main basis for dosing regimens of antipsychotics. Studies of brain kinetics may p...Continue Reading

References

Sep 1, 1993·Clinical Pharmacology and Therapeutics·M L HuangJ H Jonkman
Feb 1, 1995·The American Journal of Psychiatry·S NybergL Bertilsson
Jan 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S NybergC Halldin
Dec 1, 1996·NeuroImage·A A Lammertsma, S P Hume
Oct 8, 1999·Clinical Pharmacokinetics·J T CallaghanC M Beasley
Jun 28, 2000·Biopharmaceutics & Drug Disposition·M AravagiriS R Marder

❮ Previous
Next ❯

Citations

Feb 15, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Georges VauquelinPhilip Seeman
Mar 1, 2006·Psychopharmacology·Akihiro TakanoTetsuya Suhara
Jun 30, 2010·Psychopharmacology·Matthias ReimoldAndreas Heinz
Feb 19, 2013·Psychopharmacology·Takefumi SuzukiDavid Mamo
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Shitij KapurMing Li
Aug 7, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sandra BrunelleschiEugenio Torre
Oct 10, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dean F WongGerhard Gründer
Feb 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Anne-Marie BédardAnne-Noël Samaha
Nov 8, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Meret Martin-FacklamDean F Wong
Apr 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David MamoDavid McDonnell
Nov 6, 2007·Journal of Child and Adolescent Psychopharmacology·Wolfgang AichhornGeorg Kemmler
Jan 5, 2012·The Journal of Pharmacology and Experimental Therapeutics·E C MulyL L Howell
Sep 3, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jiamei LianChao Deng
Jun 25, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Anne-Noël Samaha
Aug 26, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jiamei LianChao Deng
Aug 1, 2009·Expert Opinion on Drug Discovery·Gianluca NucciItalo Poggesi
Oct 29, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Alexandra CharronAnne-Noël Samaha
Apr 3, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mark E SchmidtLuc Van Nueten
Jul 31, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·G MarcheseL Pani
Dec 22, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Apr 28, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Jun 11, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Paolo Fusar-PoliPhilip McGuire
Mar 6, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P Fusar-PoliP K McGuire
Dec 15, 2010·CNS Neuroscience & Therapeutics·Magdalena Nord, Lars Farde

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.